Pluri Inc.
PLUR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001158780
No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Pluri Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 15 | 21 | +6 |
| Shares | 45.1K | 56.9K | +11.9K (+26.3%) |
| Value | $272.6K | $243.8K | −$28.8K (−10.6%) |
New holders (6)
Institutions that held Pluri Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 125 | $525 | 0.00% |
| SBI Securities Co., Ltd. | 50 | $214 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 42 | $179 | 0.00% |
| Global Wealth Strategies & Associates | 8 | $34 | 0.00% |
| CBIZ Investment Advisory Services, LLC | 7 | $30 | 0.00% |
| IFP Advisors, Inc | 1 | $4 | 0.00% |
Sold out (0)
Institutions that held Pluri Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
None.